GlaxoSmithKline and Vir’s sotrovimab stands up to omicron despite other COVID antibodies falling short
Amid reports that COVID-19 antibody treatments from Regeneron and Eli Lilly lose their effectiveness against the omicron variant, GlaxoSmithKline and Vir Biotechnolog...
Continue Reading →
